semaglutide patient assistance program Novo Nordisk (PAP) Information for HCPs Savings Offer Program for patients

This protocol-defined dose-escalation approach is standard practice for this class of medication and is intended to reduce the likelihood and severity of gastrointestinal side effects during the initial treatment period

Consume 1 tablet daily

Current integrated interventions for these psychological symptoms include psychotherapy (e.g., cognitive behavioral therapy), pharmacotherapy (e.g., antidepressants), neuromodulation techniques (e.g., transcranial magnetic stimulation), hyperbaric oxygen therapy, lifestyle modifications (e.g., exercise and sleep management), and social support and rehabilitation programs

No pharmacological overlap washout is needed because both drugs are GLP-1 agonists, though re-escalating through the full semaglutide dose ladder is recommended to minimize GI side effects

(2008) and Zhao et al